Recently, the eighth batch of national organized drug centralized procurement, which attracted public attention, resulted in the proposed selection results, with a total of 39 successful drug purchases. The average price reduction of the selected drugs is 56%, and it is expected to save 16.7 billion yuan annually. Among them, the price of oseltamivir phosphate dry suspension for the treatment of influenza A was reduced by 83% on average, and the price of amlodipine atorvastatin calcium tablets, a common antihypertensive drug, was reduced by 48%. On average, 6.5 companies were selected for each variety, further enhancing supply diversification and stability. Previously, the National Medical Insurance Administration had collected 7 batches of 294 types of drugs, with an average price reduction of over 50%, and an average price reduction of over 80% for 3 batches of 4 types of consumables; By stacking local alliances for centralized procurement, the cumulative reduction in drug consumption costs has exceeded 400 billion yuan. The centralized procurement of drugs has brought tangible benefits to the people. The proportion of patients using high-quality drugs from centralized procurement has increased from 50% to over 90%, and the problem of "expensive medical treatment" has been significantly alleviated. The medical insurance fund, as the "medical treatment money" and "life-saving money" of the people, has been better protected. Medical equity is an important symbol of social equity. Not letting patients lose hope of recovering their health due to economic reasons is the simple wish of medical workers and the direction of the government's efforts to improve the health level of the people. Since the implementation of centralized drug procurement by the country, a large number of drug prices have significantly decreased, and the economic burden of patients seeking medical treatment has greatly decreased. Among them, there are drugs targeting common diseases such as influenza and hypertension, which benefit patients with daily medication needs; There are also specific drugs targeting rare diseases that bring hope to minority groups. The heartfelt words of medical insurance department staff when "soul bargaining" were "every small group should not be given up", which moved countless people and enriched their sense of gain, happiness, and security. The once expensive medicine has now become an affordable affordable drug for ordinary people, thanks to the solid work of the medical insurance department. Of course, the 'bargaining' process does not only occur in face-to-face negotiations, but also in news reports. In order to lower drug prices to the ideal level and achieve a "win-win" situation between the business interests and public interests of pharmaceutical enterprises, it is necessary to conduct in-depth research and understand the actual costs of drug research and production, and prepare a "bottom price" that is acceptable to all parties. It should be pointed out that the profound significance of promoting centralized drug procurement is not only limited to the unilateral "concession" of pharmaceutical enterprises. Centralized procurement enhances the motivation of enterprises to engage in new drug research and development, and promotes enterprises to prioritize innovation and quality. If a company lacks high-quality products, it may fall behind in the development process and be eliminated by the market. Relevant departments have also made special efforts to ensure that intellectual property rights in the domain knowledge of centralized pharmaceutical procurement are protected, and encourage R&D innovation and fair competition in the pharmaceutical industry. Centralized procurement of drugs also helps to address the issue of "selling with gold". In the past, pharmaceutical representatives from pharmaceutical companies shuttled through various medical institutions, offering rebates and other methods to increase the hospital's product procurement volume and encourage doctors to prescribe more of their drugs. This phenomenon increases the medical burden on patients, leading to a significant loss of medical insurance funds. As a "group purchase" organized by the state, drug centralized procurement can help eliminate the chaos in the field of drug distribution and sales from the source, as there are no intermediaries to make price differences. After the price reduction of drugs, it is necessary to enable the public to enjoy high-quality medical services